This site is intended for health professionals only

Search Pulse

Friday, 3 September 2010

Login: Register | Forgotten password

Newsletter sign up

E-mail sign-up
-

Advertisement

-

Advertisement

-

Advertisement

-

Advertisement

-
-

Related articles

Advertisement

Advertisement

Advertisement

Main Page Content:

Diuretic lowers heart failure risk

19 Nov 08

Chlorthalidone lowers the risk of new-onset hospitalised heart failure with preserved ejection fraction (HFPEF) and heart failure with reduced left ventricular ejection fraction (HFREF) compared with amlodipine and doxazosin, US researchers say.

An analysis of data from 900 participants in the ALLHAT trial showed chlorthalidone reduced the risk of HFPEF by 31% compared with amlodipine, 26% compared with lisinopril and 47% compared with doxazosin.

With HFREF, chlorthalidone was associated with a lower risk than amlodipine or doxazosin, but was similar to lisinopril.

Circulation 2008 10 November early online publication

Post and bookmark this story at the following sites:What is this?

Tell us your views

Please note: You must be a registered user of PulseToday and logged in to add comments. Opinions expressed below are those of the writers and do not necessarily reflect those of PulseToday. Comments are considered in the public domain and may be used in future Pulse coverage. We accept no responsibility, legal or otherwise, for the accuracy or content of member comments.

If you notice a defamatory or illegal comment, please let us know at feedback@pulsetoday.co.uk.

Post your comment

You must fill in all fields marked *

19 Nov 08

You must be logged in to add a comment

 

Main site navigation:
Skip:[To end of navigation]
Secondary site navigation:
Main site navigation end
-

Advertisement

-

Advertisement

-

Advertisement

-

Advertisement

-

Advertisement

-

Advertisement

-
 
-
Abacus E-media
Abacus e-Media
St. Andrews Court
St. Michaels Road
Portsmouth
PO1 2JH
-

Advertisement